These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Calcimimetics, mechanisms of action and therapeutic applications]. Ureña P; Legoupil N; de Vernejoul MC Presse Med; 2005 Sep; 34(15):1095-100. PubMed ID: 16334889 [TBL] [Abstract][Full Text] [Related]
7. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Nemeth EF; Steffey ME; Hammerland LG; Hung BC; Van Wagenen BC; DelMar EG; Balandrin MF Proc Natl Acad Sci U S A; 1998 Mar; 95(7):4040-5. PubMed ID: 9520489 [TBL] [Abstract][Full Text] [Related]
8. Prevention of uremic bone disease using calcimimetic compounds. Olgaard K; Lewin E Annu Rev Med; 2001; 52():203-20. PubMed ID: 11160775 [TBL] [Abstract][Full Text] [Related]
9. The extracellular calcium-sensing receptor: its role in health and disease. Brown EM; Pollak M; Hebert SC Annu Rev Med; 1998; 49():15-29. PubMed ID: 9509247 [TBL] [Abstract][Full Text] [Related]
10. Use of calcimimetics in uremic patients with secondary hyperparathyroidism: review. Ureña P Artif Organs; 2003 Sep; 27(9):759-64. PubMed ID: 12940896 [TBL] [Abstract][Full Text] [Related]
11. [Calcimimetics--a new treatment for hyperparathyroidism?]. Piecha G; Chudek J; Wiecek A Pol Merkur Lekarski; 2005 May; 18(107):581-4. PubMed ID: 16161961 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Nagano N Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839 [TBL] [Abstract][Full Text] [Related]
13. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics. Nagano N; Nemeth EF J Pharmacol Sci; 2005 Mar; 97(3):355-60. PubMed ID: 15781990 [TBL] [Abstract][Full Text] [Related]
14. Calcimimetic and calcilytic drugs: just for parathyroid cells? Nemeth EF Cell Calcium; 2004 Mar; 35(3):283-9. PubMed ID: 15200152 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion. Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163 [TBL] [Abstract][Full Text] [Related]
17. Modulation and action of the calcium-sensing receptor. Drüeke TB Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V20-26. PubMed ID: 15284356 [TBL] [Abstract][Full Text] [Related]